Ilex Medical Statistics

Total Valuation

Ilex Medical has a market cap or net worth of ILS 680.80 million. The enterprise value is 495.26 million.

Market Cap	680.80M
Enterprise Value	495.26M

Important Dates

The next estimated earnings date is Tuesday, May 27, 2025.

Earnings Date	May 27, 2025
Ex-Dividend Date	Apr 7, 2025

Share Statistics

Ilex Medical has 11.19 million shares outstanding. The number of shares has decreased by -0.02% in one year.

Current Share Class	11.19M
Shares Outstanding	11.19M
Shares Change (YoY)	-0.02%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	62.77%
Owned by Institutions (%)	17.78%
Float	2.85M

Valuation Ratios

The trailing PE ratio is 14.90.

PE Ratio	14.90
Forward PE	n/a
PS Ratio	0.74
PB Ratio	1.05
P/TBV Ratio	1.09
P/FCF Ratio	13.12
P/OCF Ratio	8.34
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.80, with an EV/FCF ratio of 9.55.

EV / Earnings	12.71
EV / Sales	0.54
EV / EBITDA	4.80
EV / EBIT	8.88
EV / FCF	9.55

Financial Position

The company has a current ratio of 2.68, with a Debt / Equity ratio of 0.08.

Current Ratio	2.68
Quick Ratio	1.88
Debt / Equity	0.08
Debt / EBITDA	0.47
Debt / FCF	0.99
Interest Coverage	26.87

Financial Efficiency

Return on equity (ROE) is 7.20% and return on invested capital (ROIC) is 5.74%.

Return on Equity (ROE)	7.20%
Return on Assets (ROA)	3.91%
Return on Invested Capital (ROIC)	5.74%
Return on Capital Employed (ROCE)	8.67%
Revenue Per Employee	5.17M
Profits Per Employee	218,994
Employee Count	178
Asset Turnover	0.92
Inventory Turnover	4.43

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.27% in the last 52 weeks. The beta is 0.02, so Ilex Medical's price volatility has been lower than the market average.

Beta (5Y)	0.02
52-Week Price Change	-2.27%
50-Day Moving Average	6,438.70
200-Day Moving Average	6,858.62
Relative Strength Index (RSI)	48.59
Average Volume (20 Days)	4,327

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ilex Medical had revenue of ILS 920.37 million and earned 38.98 million in profits. Earnings per share was 3.48.

Revenue	920.37M
Gross Profit	216.31M
Operating Income	62.93M
Pretax Income	61.60M
Net Income	38.98M
EBITDA	96.72M
EBIT	62.93M
Earnings Per Share (EPS)	3.48

Full Income Statement

Balance Sheet

The company has 236.88 million in cash and 51.35 million in debt, giving a net cash position of 185.53 million or 16.58 per share.

Cash & Cash Equivalents	236.88M
Total Debt	51.35M
Net Cash	185.53M
Net Cash Per Share	16.58
Equity (Book Value)	646.49M
Book Value Per Share	57.78
Working Capital	450.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 81.63 million and capital expenditures -29.76 million, giving a free cash flow of 51.87 million.

Operating Cash Flow	81.63M
Capital Expenditures	-29.76M
Free Cash Flow	51.87M
FCF Per Share	4.64

Full Cash Flow Statement

Margins

Gross margin is 23.50%, with operating and profit margins of 6.84% and 4.24%.

Gross Margin	23.50%
Operating Margin	6.84%
Pretax Margin	6.69%
Profit Margin	4.24%
EBITDA Margin	10.51%
EBIT Margin	6.84%
FCF Margin	5.64%

Dividends & Yields

This stock pays an annual dividend of 1.22, which amounts to a dividend yield of 2.00%.

Dividend Per Share	1.22
Dividend Yield	2.00%
Dividend Growth (YoY)	-10.63%
Years of Dividend Growth	n/a
Payout Ratio	39.16%
Buyback Yield	0.02%
Shareholder Yield	2.02%
Earnings Yield	5.73%
FCF Yield	7.62%

Dividend Details

Stock Splits

The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.

Last Split Date	Aug 21, 2000
Split Type	Forward
Split Ratio	9

Scores

Ilex Medical has an Altman Z-Score of 3.76.

Altman Z-Score	3.76
Piotroski F-Score	n/a